Children's Hospital of Philadelphia Foundation 4
4 · Spark Therapeutics, Inc. · Filed Sep 27, 2017
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-09-27−6,000→ 0 total(indirect: By Affiliate)Exercise: $56.22From: 2017-06-01Exp: 2026-05-31→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2017-09-27$56.22/sh+6,000$337,320→ 3,954,957 total - Exercise/Conversion
Stock Option (right to buy)
2017-09-27−20,250→ 0 total(indirect: By Affiliate)Exercise: $23.00Exp: 2025-01-30→ Common Stock (20,250 underlying) - Exercise/Conversion
Common Stock
2017-09-27$23.00/sh+20,250$465,750→ 3,948,957 total
Footnotes (2)
- [F1]This option was granted on January 30, 2015 to A. Lorris Betz, MD, Ph.D., a member of the Board of Trustees and Executive Committee of the Reporting Person and a former member of the Board of Directors of the Issuer. The option vests quarterly over four years. Dr. Betz holds this option for the benefit of the Reporting Person.
- [F2]This option was granted on June 1, 2016 to Dr. Betz, who holds this option for the benefit of the Reporting Person.